Analyze Diet
The Veterinary clinics of North America. Equine practice2026; S0749-0739(25)00071-9; doi: 10.1016/j.cveq.2025.12.003

Update on Idiopathic Trigeminal-Mediated Headshaking.

Abstract: Idiopathic trigeminal-mediated headshaking is a painful neuropathic disorder characterized by sudden, violent, predominantly vertical head movements of unknown etiology. Clinical signs may be seasonal or persistent and triggered by light, sound, exercise, or tactile nasal stimulation. The pathophysiology is multifactorial, involving abnormal trigeminal nerve excitability influenced by hormonal, environmental, and dietary factors. Treatment is challenging and typically multimodal, aiming to reduce trigeminal hypersensitivity and improve quality of life.
Publication Date: 2026-02-20 PubMed ID: 41723007DOI: 10.1016/j.cveq.2025.12.003Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • Idiopathic trigeminal-mediated headshaking is a painful nerve disorder causing sudden, violent head movements in horses.
  • The exact cause is unknown, and symptoms can vary, sometimes triggered by environmental stimuli.
  • Treatment is complex and usually involves multiple approaches to reduce nerve sensitivity and improve life quality.

Introduction to Idiopathic Trigeminal-Mediated Headshaking

  • It is a neuropathic disorder primarily affecting horses, characterized by intense head shaking movements.
  • The head movements are predominantly vertical and can be sudden and forceful.
  • Referred to as “idiopathic” due to an unknown or unclear etiology.

Clinical Presentation

  • Symptoms may be seasonal—occurring only at certain times of the year—or persistent without clear timelines.
  • Triggers often include external stimuli such as:
    • Light exposure
    • Sounds
    • Exercise
    • Tactile stimulation of the nasal area
  • Animals may experience pain and discomfort, impacting their behavior and performance.

Pathophysiology and Causes

  • The underlying pathophysiology is multifactorial, meaning multiple factors contribute to the disorder.
  • There is abnormal excitability or increased sensitivity of the trigeminal nerve, which is the main nerve responsible for facial sensation.
  • Influencing factors include:
    • Hormonal changes, which might affect nerve excitability
    • Environmental elements such as weather or allergens
    • Dietary influences that may modulate nerve function or inflammation

Treatment Approaches

  • Treatment is challenging due to the complex, multifactorial nature of the disorder.
  • Usually involves a multimodal approach combining different therapies aimed to:
    • Reduce trigeminal nerve hypersensitivity
    • Manage pain effectively
    • Improve the animal’s quality of life and functional ability
  • Examples of treatment modalities may include:
    • Medications such as anticonvulsants or nerve modifiers
    • Environmental or lifestyle changes
    • Alternative therapies like acupuncture or nerve blocks

Conclusion

  • Idiopathic trigeminal-mediated headshaking remains a difficult condition to manage due to unknown etiology and varied clinical presentation.
  • Ongoing research aims to better understand the pathophysiology and develop more effective treatments.
  • Multimodal treatment strategies are currently the best approach to help affected animals live more comfortably.

Cite This Article

APA
Aleman M, Morales CJ. (2026). Update on Idiopathic Trigeminal-Mediated Headshaking. Vet Clin North Am Equine Pract, S0749-0739(25)00071-9. https://doi.org/10.1016/j.cveq.2025.12.003

Publication

ISSN: 1558-4224
NlmUniqueID: 8511904
Country: United States
Language: English
PII: S0749-0739(25)00071-9

Researcher Affiliations

Aleman, Monica
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA. Electronic address: mraleman@ucdavis.edu.
Morales, Camilo J
  • K.L. Maddy Lab, Equine Clinical Pharmacology, Equine Medicine-VMTH, University of California, Davis, Davis, CA 95616, USA; School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USA. Electronic address: cjaramillomorales@ucdavis.edu.

Conflict of Interest Statement

Disclosure The authors declare that certain medications discussed in this manuscript are used in an extra-label manner, and that some therapeutic agents described do not have approval from the United States Food and Drug Administration for use in horses.

Citations

This article has been cited 0 times.